Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced Solid Tumors (MK-4280-001)
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-045)
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Genetic Predictors of Benefit to Pembrolizumab
- Status
- TERMINATED
- Phase
- PHASE2
A Phase II Study of Pembrolizumab as Post-Remission Treatment of Patients ≥ 60 With AML
- Status
- COMPLETED
- Phase
- PHASE2
Observational, Retrospective Analysis in HIV-1 Infected Patients. (ORASWIRAL)
- Status
- COMPLETED
- Phase
- N/A
Switch Maintenance Pembrolizumab in Patients With NSCLC After First Line Platinum Doublet Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Suvorexant and Trauma Related Insomnia
- Status
- COMPLETED
- Phase
- PHASE4
Surgical Conditions During Laparoscopic Bariatric Surgery
- Status
- COMPLETED
- Phase
- PHASE4
Pembrolizumab and GM-CSF in Biliary Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) vs. Best Supportive Care in Participants With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-240/KEYNOTE-240)
- Status
- COMPLETED
- Phase
- PHASE3
A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile
- Status
- COMPLETED
- Phase
- PHASE2
Recovery of Muscle Function After Deep Neuromuscular Block by Means of Diaphragm Ultrasonography
- Status
- UNKNOWN
- Phase
- PHASE4
A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Hematologic Malignancies (MK-8628-005)
- Status
- TERMINATED
- Phase
- PHASE1
A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Advanced Solid Tumors (MK-8628-006)
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy Study of Pembrolizumab With Entinostat to Treat Metastatic Melanoma of the Eye
- Status
- COMPLETED
- Phase
- PHASE2